(306f) Cell Membrane-Camouflaged Nanomotors for Biodetoxification and Drug Delivery | AIChE

(306f) Cell Membrane-Camouflaged Nanomotors for Biodetoxification and Drug Delivery

Authors 

Wang, J., University of California, San Diego
Attempts to apply artificial micro-/nanomotors for diverse biomedical applications have inspired a variety of strategies for designing motors with diverse propulsion mechanisms and functions. However, existing artificial motors are made exclusively of synthetic materials, which are subject to serious immune attack and clearance upon entering the bloodstream. Herein we present a platform by using red blood cell as camouflage coating for micro-/nanomotors. As the first example, a red blood cell membrane-camouflaged nanowire that can serve as new generation of biomimetic motor sponge is described. The biomimetic motor sponge is constructed by the fusion of biocompatible gold nanowire motors and RBC nanovesicles. The motor sponge possesses a high coverage of RBC vesicles, which remain totally functional due to its exclusively oriented extracellular functional portion on the surfaces of motor sponge. These biomimetic motors display efficient acoustical propulsion, including controlled movement in undiluted whole blood. The RBC vesicles on the motor sponge remain highly stable during the propulsion process, conferring thus the ability to absorb membrane-damaging toxins and allowing the motor sponge to be used as efficient toxin decoys. The efficient propulsion of the motor sponges under an ultrasound field results in accelerated neutralization of the membrane-damaging toxins. Such motor sponges connect artificial nanomotors with biological entities and hold great promise for treating a variety of injuries and diseases caused by membrane-damaging toxins.
As another example, an elegant approach is used to directly turn natural red blood cells (RBCs) into functional micromotors with the aid of ultrasound propulsion and magnetic guidance. Since the RBC motors preserve the biological and structural features of regular RBCs, these motors possess a wide range of antigenic, transport, and mechanical properties that common synthetic motors cannot achieve and thus hold considerable promise for a number of practical biomedical uses. The ability of the RBC micromotors to transport imaging and therapeutic agents at high speed and spatial precision through a complex microchannel network is also demonstrated. Such ability to load and transport diagnostic imaging agents and therapeutic drugs within a single cell-based motor, in addition to a lower toxicity observed once the drug is encapsulated within the multicargo RBC motor, opens the door to the development of theranostic micromotors that may simultaneously treat and monitor diseases.